New Treatment Shows Promise Against Peanut Allergy

A new drug derived from peanuts, can provide protection to children suffering from peanut allergy.

In a first, an oral immunotherapy drug derived from peanut protein could help build tolerance and eliminate potentially deadly reactions in children and adolescents with severe peanut allergies.

The study, published in the New England Journal of Medicine, showed that controlled ingestion of the medication, called AR101, derived from peanut protein, could build tolerance as well as reduce severe allergy symptoms.